Twenty-four HIV + adults with metabolic complications including peripheral insulin resistance were randomly assigned to 4 months of pioglitazone ( PIO ; 30 mg/d ) or supervised , progressive endurance and resistance exercise training ( EXS ; 90-120 min/d , 3 d/wk ) .